This $6,336 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community. The contract is for the delivery of Benchmark FBS - 500mL, catalog #100106. Gemini Bioproducts has received numerous prior awards from NIH to supply fetal bovine serum for cell...
This federal contract award, valued at $77,738.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Gemini Bioproducts LLC. The contract is for the procurement of a benchmark fetal bovine serum (FBS) lot to support research characterizing the infectious properties of SARS-CoV-2 variants and developing effective prophylactic and therapeutic vaccine candidates. This is a sole source award, as the specified FBS lot...
This federal contract award to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media and other biomedical research supplies, is for the delivery of fetal bovine serum under Purchase Order HHSN272201001085P. The $5,027.40 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for the supply of BENCHMARK fetal bovine serum. Gemini Bioproducts has previously received numerous...
This is a $13,451.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract is for the delivery of fetal bovine serum from Gemini Bioproducts LLC, a for-profit manufacturer and supplier of cell culture media, sera, and other reagents. This award does not have a set-aside designation. Gemini Bioproducts has previously received numerous orders...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. The $57,375.00 firm-fixed-price purchase order was for the delivery of 500 mL of benchmark fetal bovine serum, a critical cell culture component used in biomedical research. This order is part of NIAID's ongoing procurement of specialized cell culture media and reagents to support its diverse scientific initiatives....
This federal contract award to Gemini Bioproducts LLC, a leading manufacturer of cell culture media and reagents, is for the purchase of 60 500 mL bottles of fetal bovine serum (FBS). The $20,130 firm fixed price contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), with a completion date of January 15, 2016. Gemini Bioproducts has a history of providing FBS and other products to federal agencies...
This firm fixed-price purchase order was awarded to Gemini Bioproducts LLC, a for-profit manufacturer of goods, by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The $102,116.06 contract is for the delivery of fetal bovine serum, and is designated as a Total Small Business set-aside. Gemini Bioproducts is a leading supplier of cell culture media, sera, and other reagents to the scientific community, including...
This federal contract award was issued by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a civilian agency, to Gemini Bioproducts LLC, a for-profit manufacturer of cell culture media and related products. The $10,239.66 firm fixed price contract is for the provision of fetal bovine serum, which is required to culture primary cells and cell lines used in the Ombrello Lab. This appears to be a Blanket Purchase Agreement (BPA) call order, with a ceiling value...
This $3,501.23 firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Gemini Bioproducts LLC. Gemini Bioproducts is a leading manufacturer and supplier of cell culture media, sera, and other reagents to the scientific community, including academic research and the biotechnology, cell and gene therapy, and biopharma industries. The contract is to provide fetal bovine serum, viral...
This is a federal contract award to Gemini Bioproducts LLC, a leading manufacturer and supplier of cell culture media, sera, and other reagents, by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH). The contract has a total ceiling value of $26,000.00 and is for the supply of biomaterial products. The contract type is a firm fixed-price purchase order, with an ultimate completion date of October 21, 2015. This award is not associated...